Teladoc Health Stock (TDOC): $118 Price Target From Piper Sandler

By Amit Chowdhry ● Jan 11, 2022
  • The shares of Teladoc Health Inc (NYSE: TDOC) have received a $118 price target from Piper Sandler. These are the details.

The shares of Teladoc Health Inc (NYSE: TDOC) have received a $118 price target from Piper Sandler. And Piper Sandler analyst Sean Wieland reduced the price target from $183 while maintaining an “Overweight” rating on the shares.

Wieland noted that the company’s three-year operating targets issued at the November investor day were below projections in terms of revenue and profitability.

Going forward, Wieland noted that Teladoc’s integration efforts are much less mature than we appreciated. But Wieland is encouraged that the company is investing in a unified platform.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.